Iradimed Corp [IRMD] stock is trading at $58.21, up 2.65%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The IRMD shares have gain 5.84% over the last week, with a monthly amount glided 7.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Iradimed Corp [NASDAQ: IRMD] stock has seen the most recent analyst activity on April 12, 2023, when Lake Street initiated its Buy rating and assigned the stock a price target of $50. On October 05, 2016, downgrade downgraded it’s rating to Neutral. ROTH Capital reiterated its Buy rating and increased its price target to $30 on November 02, 2015. ROTH Capital reiterated its recommendation of a Buy and raised its price target to $25 on July 30, 2015. ROTH Capital reiterated a Buy rating for this stock on June 16, 2015, and upped its price target to $23. In a note dated January 12, 2015, ROTH Capital reiterated an Buy rating on this stock and boosted its target price from $15 to $18.
Iradimed Corp [IRMD] stock has fluctuated between $40.18 and $57.95 over the past year. Currently, Wall Street analysts expect the stock to reach $60 within the next 12 months. Iradimed Corp [NASDAQ: IRMD] shares were valued at $58.21 at the most recent close of the market. An investor can expect a potential return of 3.08% based on the average IRMD price forecast.
Analyzing the IRMD fundamentals
Iradimed Corp [NASDAQ:IRMD] reported sales of 71.31M for the trailing twelve months, which represents a growth of 11.04%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.3%, Pretax Profit Margin comes in at 0.33%, and Net Profit Margin reading is 0.26%. To continue investigating profitability, this company’s Return on Assets is posted at 0.2, Equity is 0.24 and Total Capital is 0.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 56.83 points at the first support level, and at 55.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 59.00, and for the 2nd resistance point, it is at 59.79.
Ratios To Look Out For
For context, Iradimed Corp’s Current Ratio is 9.21. Also, the Quick Ratio is 7.82, while the Cash Ratio stands at 6.41. Considering the valuation of this stock, the price to sales ratio is 10.35, the price to book ratio is 8.84 and price to earnings (TTM) ratio is 39.87.
Transactions by insiders
Recent insider trading involved GLENN JOHN, Officer, that happened on Dec 02 ’24 when 2500.0 shares were purchased. CHIEF FINANCIAL OFFICER, GLENN JOHN completed a deal on Dec 02 ’24 to sell 2500.0 shares. Meanwhile, Director VUOTO ANTHONY sold 2690.0 shares on Nov 06 ’24.
